Nutritional Epidemiology Program, Jean Mayer US Department of Agriculture, Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA.
The Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.
J Nutr. 2020 Jun 1;150(6):1545-1553. doi: 10.1093/jn/nxaa068.
Although greater flavonoid intake is associated with a reduced risk of Alzheimer's disease (AD) and related dementias (ADRD), evidence relating dietary flavonoid intake to brain health based on MRI is lacking.
The objective of this study was to explore the association between dietary flavonoid intake and MRI measures of brain health, including total brain tissue volume (TBV), white matter hyperintensities volume (WMHV), and hippocampal volume (HV).
Eligible subjects included members of the Framingham Heart Study Offspring Cohort who were free of stroke at exam 7 and had at least 1 valid food frequency questionnaire from exams 5, 6, or 7 (n = 2086; mean age at exam 7, 60.6 y). Flavonoid intakes represented the cumulative mean of intakes across the 3 exams and were categorized based on quartiles categories of intake. TBV, WMHV, and HV were assessed at exam 7. Multiple linear regression models were used to examine the cross-sectional association between total and the 6 classes of flavonoids and the 3 aforementioned MRI measures.
The mean (95% CI) of the WMHV of subjects in the highest quartile category of flavan-3-ols [0.56 (0.52, 0.61)] and flavonoid polymers [0.57 (0.52, 0.61)] intake was significantly smaller relative to that of subjects in the lowest quartile category of flavan-3-ols [0.65 (0.60, 0.71)] and flavonoid polymers [0.66 (0.60, 0.71)] after accounting for important demographic, lifestyle, and clinical factors. Inverse trend associations with WMHV were also seen for flavan-3-ols (P = 0.01) and flavonoid polymers (P = 0.01) as well as for total flavonoids (P = 0.01). TBV and HV were not associated with dietary flavonoid intake following the adjustment for potential confounders.
Our results contribute to the literature on flavonoids and ADRD as they suggest that higher flavonoid intakes may affect ADRD risk in middle-aged and older adults by reducing WMHV, a marker strongly associated with ADRD.
尽管黄酮类化合物的摄入量与阿尔茨海默病(AD)和相关痴呆(ADRD)的风险降低有关,但基于 MRI 评估饮食黄酮类化合物摄入量与大脑健康之间的关系的证据尚缺乏。
本研究旨在探索饮食黄酮类化合物摄入量与 MRI 测量的大脑健康指标(包括总脑组织体积[TBV]、脑白质高信号体积[WMHV]和海马体积[HV])之间的关系。
符合条件的受试者包括弗雷明汉心脏研究后代队列的成员,他们在第 7 次检查时没有中风,并且至少有 1 份来自第 5、6 或 7 次检查的有效食物频率问卷(n=2086;第 7 次检查时的平均年龄为 60.6 岁)。黄酮类化合物的摄入量代表了 3 次检查的摄入量平均值,并根据摄入量的四分位数类别进行分类。TBV、WMHV 和 HV 在第 7 次检查时进行评估。采用多元线性回归模型来检验黄酮类化合物的总摄入量和 6 个类别与上述 3 个 MRI 测量指标之间的横断面关系。
在摄入最高四分位数类别的黄烷-3-醇[0.56(0.52,0.61)]和黄酮聚合物[0.57(0.52,0.61)]的受试者中,WMHV 的平均值(95%CI)显著小于摄入最低四分位数类别的黄烷-3-醇[0.65(0.60,0.71)]和黄酮聚合物[0.66(0.60,0.71)],这在考虑到重要的人口统计学、生活方式和临床因素后也是如此。WMHV 与黄烷-3-醇(P=0.01)和黄酮聚合物(P=0.01)以及总黄酮类化合物(P=0.01)也呈负相关趋势。在调整潜在混杂因素后,TBV 和 HV 与饮食黄酮类化合物摄入无关。
我们的研究结果为黄酮类化合物与 ADRD 相关的文献做出了贡献,因为它们表明,在中年和老年人中,较高的黄酮类化合物摄入量可能通过降低脑白质高信号体积(WMHV)来影响 ADRD 风险,WMHV 是与 ADRD 密切相关的标志物。